Satoru Matsuda MD, PhD, Tomoyuki Irino MD, MSc, PhD, Akihiko Okamura MD, PhD, Shuhei Mayanagi MD, PhD, Eisuke Booka MD, PhD, Masashi Takeuchi MD, PhD, Hirofumi Kawakubo MD, PhD, Hiroya Takeuchi MD, PhD, FACS, Masayuki Watanabe MD, PhD & Yuko Kitagawa MD, PhD, FACS
Read Abstract: Endoscopic Evaluation of Pathological Complete Response Using Deep Neural Network in Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy—Multicenter Retrospective Study from Four Japanese Esophageal Centers
Feng Su MD, Xinyu Yang MD, Jun Yin MD, Yaxing Shen MD & Lijie Tan MD, FACS
Read Abstract: Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis
Shaoyuan Zhang MD, Linyi Sun MM, Danjie Cai MD, Guobing Liu MD, Dongxian Jiang MD, Jun Yin PhD, Yong Fang MD, Hao Wang MD, Yaxing Shen MD, Yingyong Hou MD, Hongcheng Shi MD & Lijie Tan MD
Read Abstract: Development and Validation of PET/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma
Yong Ao MD, JiuDi Zhong MD, LeQi Zhong MD, KongJia Luo MD, PhD, Xin Zhang MD, XiaoDan Lin BS, ChuanZhen Li BS, TianZhen Yang BS, LiHong Qiu BS, ShiNing Li MD & Yi Hu MD, PhD
Read Abstract: Effect of Intrathoracic or Cervical Anastomosis After Esophagectomy on Quality of Life
Florian Gebauer MD, Patrick S. Plum MD, Alexander Damanakis MD, Seung-Hun Chon MD, Felix Popp MD, Thomas Zander MD, Alexander Quaas MD, Hans Fuchs MD, Thomas Schmidt MD, Wolfgang Schröder MD & Christiane J. Bruns MD
Read Abstract: Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
Uzair M. Jogiat MD, Vickie Baracos PhD, Simon R. Turner MD, Dean Eurich PhD, Heather Filafilo RD, Armin Rouhi MD, Alexandre Bédard & Eric L. R. Bédard MD
Read Abstract: Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal Cancer
Matthieu Faron , MD1; Maurice Cheugoua-Zanetsie , MSc1; Jayne Tierney, PhD2; Pierre Thirion, MD3; Matthew Nankivell , PhD2; Kathryn Winter, PhD4; Hong Yang , MD5; Joel Shapiro , MD6; Dewi Vernerey, PhD7; B. Mark Smithers, MD8; Thomas Walsh, MD9; Guillaume Piessen , MD10; Magnus Nilsson, MD11,12; Jurjen Boonstra , MD13; Marc Ychou, MD14; Simon Law, MD15; David Cunningham , MD16; Florent de Vathaire , PhD1; Michael Stahl, MD17; Susan Urba, MD18; Michele Valmasoni , MD19; Danièle Williaume, MD20; Janine Thomas, MD21; Florian Lordick, MD22; Joel Tepper , MD23; Jack Roth, MD24; Val Gebski , PhD25; Bryan Burmeister, PhD21; Xavier Paoletti , PhD26; Johanna van Sandick, MD27; Jianhua Fu , MD5; Jean-Pierre Pignon , MD1; Michel Ducreux, MD28; and Stefan Michiels , PhD1; on behalf of the MANATEC-02 Collaborative Group
Read Abstract: Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma
Jonathan L. Moore , FRCS1,2; Michael Green, FRCPath3; Aida Santaolalla, PhD2; Harriet Deere, FRCPath3; Richard P.T. Evans, MRCS4; Mona Elshafie, MD, FRCPath5; Anita Lavery , MD6; Damian T. McManus, MD, FRCPath7; Andrew McGuigan , MB, MRCS6; Rosalie Douglas , MD, PhD6; Joanne Horne, FRCPath8; Robert Walker , FRCS9; Hira Mir, FRCPath10; Monica Terlizzo, FRCPath10; Sivesh K. Kamarajah , MRCS5; Mieke Van Hemelrijck, PhD2; Nick Maisey, MD, FRCP11; Ailsa Sita-Lumsden, PhD, MRCP11; Sarah Ngan, PhD, FRCP11; Mark Kelly , MRes, FRCS1,2; Cara R. Baker, PhD, FRCS1,2; Sacheen Kumar , PhD, FRCS12; Jesper Lagergren , MD, PhD1,2,13; William H. Allum, MD, FRCS12; James A. Gossage, MS, FRCS1,2; Ewen A. Griffiths , MD, MFST, FRCS5; Heike I. Grabsch , MD, PhD, FRCPath14,15; Richard C. Turkington , MD, PhD6; Tim J. Underwood , PhD, FRCS9; Elizabeth C. Smyth, MD16; Rebecca C. Fitzgerald , MD, FMedSci17,18; David Cunningham , MD, FRCP, FMedSci19; Andrew R. Davies, MD, FRCS1,2; on behalf of The Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study group, The Guy's and St Thomas' Oesophago-gastric Research Group, and The PROGRESS study group
Read Abstract: Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom
Vidhi Patel MD, Madhusudhan R. Sanaka MD, Yi Qin MD, John McMichael PhD, James Bena MS, Claire Beveridge MD, John Barron MD, Siva Raja MD, Jamak Modaresi Esfeh MD & Prashanthi N. Thota MD
Read Abstract: Neoplastic Progression of Barrett’s Esophagus Among Organ Transplant Recipients: a Retrospective Cohort Study
Lye-Yeng Wong, Matthew Leipzig, Douglas Z. Liou, Leah M. Backhus, Natalie S. Lui, Joseph B. Shrager & Mark F. Berry
Read Abstract: Surgical Management of Esophageal Perforation: Examining Trends in a Multi-Institutional Cohort
The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.
General Inquiries: info@isde.net Membership Questions: membership@isde.net